With the widespread use of RNA sequencing technology, the EWSR1/FUS::CREB fusion mesenchymal tumor family has expanded rapidly to include potentially aggressive tumors rather than any well-established WHO entity. The gene discussed is EWSR1; the disease is neoplasm.